title

Diabetes Discourse

ReachMD

3
Followers
17
Plays
Diabetes Discourse
Diabetes Discourse

Diabetes Discourse

ReachMD

3
Followers
17
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

Latest Episodes

A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General

Guest: Regina Benjamin, MD, MS As healthcare providers, it’s our duty to emphasize the importance of preventing the eye-health consequences associated with diabetes, particularly as it pertains to health disparities and underserved populations. This activity featuring Dr. Regina Benjamin serves as a call to action by discussing the essential roles that all healthcare professionals play in the overall eye-health of our patients to reduce visual impairment due to diabetic retinopathy. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

6 MINSEP 15
Comments
A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General

On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations

Host: Anne Peters, MD Guest: Thomas W. Gardner, MD, MS Guest: Diana Shechtman, OD, FAAO Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with Dr. Anne Peters, Dr. Thomas Gardner, and Dr. Diana Shechtman, who also discuss how endocrinologists and primary care providers can work together with eye care professionals to actively optimize vision outcomes for patients at risk for diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

15 MINSEP 15
Comments
On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations

In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

17 MINSEP 15
Comments
In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients with diabetes are not receiving routine eye exams and are at risk of vision loss. Making matters worse is the fact that many patients with diabetes remain unaware that this disease can affect their vision. That’s why this discussion with a panel of expert faculty will examine what it means to be proactive in promoting vision screening and minimizing the risk for vision loss with appropriate early treatment in these patients. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

16 MINSEP 15
Comments
Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

Diabetes Cardiovascular Outcomes Trials: What You Need to Know

Guest: Michael H. Davidson, MD Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, and how these studies are designed and assessed. US19HCP00067 July 2019

18 MINAUG 27
Comments
Diabetes Cardiovascular Outcomes Trials: What You Need to Know

Role of the Cardiologist in T2D Management

Host: Jennifer Caudle, DO Guest: Christie Ballantyne, MD With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne. US18VZ00285 January 2019

8 MINFEB 26
Comments
Role of the Cardiologist in T2D Management

Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Guest: Christie Ballantyne, MD Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne. US18VZ00286 January 2019

13 MINFEB 12
Comments
Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

The Role of the Certified Diabetes Educator: A Team Effort

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified diabetes educators to help empower diabetes patients and improve long-term outcomes. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

16 MIN2015 AUG 31
Comments
The Role of the Certified Diabetes Educator: A Team Effort

Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes

Host: John J. Russell, MD Guest: Serena Cardillo, MD Host Dr. John Russell welcomes Dr. Serena Cardillo, Associate Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism at Penn Medicine. Dr. Cardillo guides listeners through the challenges in treating diabetic patients whose blood glucose levels remain poorly controlled. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

-1 s2015 AUG 24
Comments
Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes

Toward a Healthier Journey for the Type 2 Diabetes Patient

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed to instill a positive and healthy approach to diabetes care. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

-1 s2015 AUG 17
Comments
Toward a Healthier Journey for the Type 2 Diabetes Patient

Latest Episodes

A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General

Guest: Regina Benjamin, MD, MS As healthcare providers, it’s our duty to emphasize the importance of preventing the eye-health consequences associated with diabetes, particularly as it pertains to health disparities and underserved populations. This activity featuring Dr. Regina Benjamin serves as a call to action by discussing the essential roles that all healthcare professionals play in the overall eye-health of our patients to reduce visual impairment due to diabetic retinopathy. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

6 MINSEP 15
Comments
A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General

On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations

Host: Anne Peters, MD Guest: Thomas W. Gardner, MD, MS Guest: Diana Shechtman, OD, FAAO Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with Dr. Anne Peters, Dr. Thomas Gardner, and Dr. Diana Shechtman, who also discuss how endocrinologists and primary care providers can work together with eye care professionals to actively optimize vision outcomes for patients at risk for diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

15 MINSEP 15
Comments
On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations

In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

17 MINSEP 15
Comments
In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients with diabetes are not receiving routine eye exams and are at risk of vision loss. Making matters worse is the fact that many patients with diabetes remain unaware that this disease can affect their vision. That’s why this discussion with a panel of expert faculty will examine what it means to be proactive in promoting vision screening and minimizing the risk for vision loss with appropriate early treatment in these patients. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

16 MINSEP 15
Comments
Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

Diabetes Cardiovascular Outcomes Trials: What You Need to Know

Guest: Michael H. Davidson, MD Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, and how these studies are designed and assessed. US19HCP00067 July 2019

18 MINAUG 27
Comments
Diabetes Cardiovascular Outcomes Trials: What You Need to Know

Role of the Cardiologist in T2D Management

Host: Jennifer Caudle, DO Guest: Christie Ballantyne, MD With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne. US18VZ00285 January 2019

8 MINFEB 26
Comments
Role of the Cardiologist in T2D Management

Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Guest: Christie Ballantyne, MD Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne. US18VZ00286 January 2019

13 MINFEB 12
Comments
Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

The Role of the Certified Diabetes Educator: A Team Effort

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified diabetes educators to help empower diabetes patients and improve long-term outcomes. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

16 MIN2015 AUG 31
Comments
The Role of the Certified Diabetes Educator: A Team Effort

Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes

Host: John J. Russell, MD Guest: Serena Cardillo, MD Host Dr. John Russell welcomes Dr. Serena Cardillo, Associate Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism at Penn Medicine. Dr. Cardillo guides listeners through the challenges in treating diabetic patients whose blood glucose levels remain poorly controlled. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

-1 s2015 AUG 24
Comments
Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes

Toward a Healthier Journey for the Type 2 Diabetes Patient

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed to instill a positive and healthy approach to diabetes care. Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only. Brought to you by

-1 s2015 AUG 17
Comments
Toward a Healthier Journey for the Type 2 Diabetes Patient
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。